[go: up one dir, main page]

ZA201803649B - Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases - Google Patents

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Info

Publication number
ZA201803649B
ZA201803649B ZA201803649A ZA201803649A ZA201803649B ZA 201803649 B ZA201803649 B ZA 201803649B ZA 201803649 A ZA201803649 A ZA 201803649A ZA 201803649 A ZA201803649 A ZA 201803649A ZA 201803649 B ZA201803649 B ZA 201803649B
Authority
ZA
South Africa
Prior art keywords
treatment
diseases
prevention
attenuated influenza
oncological
Prior art date
Application number
ZA201803649A
Inventor
Andrei Yurievich Egorov
Boris Ferko
Artem Alexandrovich Krokhin
Yulia Romanovna Romanova
Original Assignee
«Pharmenterprises Biotech» Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2015147703A external-priority patent/RU2628690C2/en
Priority claimed from RU2016111907A external-priority patent/RU2660562C2/en
Application filed by «Pharmenterprises Biotech» Llc filed Critical «Pharmenterprises Biotech» Llc
Publication of ZA201803649B publication Critical patent/ZA201803649B/en

Links

ZA201803649A 2015-11-06 2018-05-31 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases ZA201803649B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2015147703A RU2628690C2 (en) 2015-11-06 2015-11-06 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases, as well as for cancer treatment
RU2016111907A RU2660562C2 (en) 2016-03-30 2016-03-30 Attenuated grippose vector and mucosal universal grippose vaccine on its basis
PCT/RU2016/050066 WO2017078577A2 (en) 2015-11-06 2016-11-03 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Publications (1)

Publication Number Publication Date
ZA201803649B true ZA201803649B (en) 2019-11-27

Family

ID=62748489

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201803649A ZA201803649B (en) 2015-11-06 2018-05-31 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Country Status (3)

Country Link
CL (1) CL2018001201A1 (en)
EA (1) EA037571B1 (en)
ZA (1) ZA201803649B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69934885T2 (en) * 1998-06-12 2007-11-08 Mount Sinai School Of Medicine Of The City University Of New York NEW METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE IMPROVEMENT OF VIRUSES
AU2001250352B2 (en) * 2000-03-02 2006-01-12 Polymun Scientific Immunbiologische Forschung Gmbh Recombinant influenza a viruses
US7037707B2 (en) * 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines

Also Published As

Publication number Publication date
EA201792083A1 (en) 2018-07-31
CL2018001201A1 (en) 2018-09-21
EA037571B1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL255259B (en) Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases
IL245436A0 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
IL246449B (en) 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
ZA201708039B (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
PT3262037T (en) A new quinoline derivative for use in the treatment and prevention of viral infections
IL263368A (en) Prevention and treatment of viral infections
GB201611712D0 (en) Methods and compounds for the treatment or prevention of severe or persistent influenza
ZA201705634B (en) Quinoline derivatives for use in the treatment or prevention of viral infection
IL249660A0 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections
PL3183003T3 (en) Methods for prevention and/or treatment of infection
GB201413530D0 (en) Treatment and prevention of malaria
SG11201705889VA (en) Prevention or Treatment of Uratic or Gouty Diseases
SI3197556T1 (en) Composition for the prevention and/or treatment of allergy symptoms
PT3800257T (en) Pan-genotypic agents against influenza virus and methods of using the same
LT3360580T (en) GENETIC TREATMENT FOR AAV-XBP1S / GFP VIRUS AND ITS USE FOR THE PREVENTION AND TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
GB201615035D0 (en) Treatment and prevention of viral infection
PL3095866T3 (en) Agent for the prophylaxis and therapy of viral infections
ZA201803649B (en) Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases
PL3490604T3 (en) Medicament for the treatment and/or prevention of endometriosis
GB201520019D0 (en) The genome and self-evolution of AI
GB201522828D0 (en) Prevention and treatment of glaucoma
AU2014900488A0 (en) Agents and methods for inhibiting virus infection